DOMINANT ANGLE
Lima retains from the Nobel Prize in Medicine the therapeutic promise of optogenetics: a method to decipher the mysteries of the brain, already tested to restore vision to partially sighted individuals.
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- 01
The 2026 Nobel Prize in Medicine is awarded to Karl Deisseroth (United States), Peter Hegemann, and Georg Nagel (Germany) for light-activated ion channels and optogenetics, announced Monday, October 5, by the Nobel Assembly at Karolinska.
- 02
According to the jury, optogenetics has revealed neural circuits of memories, emotions, and behaviors related to neurological and psychiatric disorders.
- 03
In clinics, researchers are using the method in attempts to restore vision in people with visual impairment.
ANALYSIS
Lima, October 6, 2026. The official Andina agency and the economic daily Gestión cover the 2026 Nobel Prize in Physiology or Medicine in almost identical terms, both constructed from the text of the announcement made on Monday, October 5, from Stockholm. The prize goes to American Karl Deisseroth and Germans Peter Hegemann and Georg Nagel "for their discoveries on light-activated ion channels and optogenetics," according to the Nobel Assembly of the Karolinska Institute.
The two headlines present optogenetics as a method that shows how nerve cells shape memories, feelings, and behaviors in the living brain. They quote the jury, which says these works "have laid the foundation for a new era in neuroscience." They also repeat the jury's phrase that optogenetics "has radically transformed our understanding of the brain," with new discoveries every day about "one of the great mysteries of humanity."
The medical dimension is the most emphasized. Thanks to this technique, researchers have been able to uncover the neural circuits that control memories, emotions, and behaviors related to neurological and psychiatric disorders. The articles add that in clinical medicine, researchers are using it to try to restore vision in people with visual impairments.
The scientific narrative occupies the rest of the text. In the early 2000s, Hegemann and Nagel discovered channelrhodopsin, an algal protein on the cell surface: when exposed to blue light, it opens a channel, charged ions enter the cell, and produce an electrical impulse. The articles recall that Hegemann wondered how Chlamydomonas, a unicellular alga, manages to swim towards a light source.
The coverage remains factual and didactic, without national commentary: none of the articles in this corpus mention Peruvian laboratories, researchers, or scientific policies. Gestión titles its paper with a question, "what did they discover?", a sign of a popularization approach for a non-specialist readership, while Andina titles it on the technique "that helps decipher the mysteries of the brain." In both cases, the prize is treated as international news relayed from a dispatch, and not as a funding issue for research or rivalry between countries.
